TQ Quiz | The ABCs of Thyroid Eye Disease – Antibodies, Biologics, and Clinical Pearls (Quebec 2024) by Events@optometricedu.com | Aug 21, 2024 | 2024 Quebec, TQ Courses | 0 comments "*" indicates required fields This field is hidden when viewing the formDate (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent 60 days past date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date Difference (Hidden)1. The thyroid is what type of gland?* A - Serous B - Sebaceous C - Exocrine D - Endocrine 2. Which structure of the body has endocrine and exocrine features?* A - Thyroid gland B - Pancreas C - Pituitary gland D - Parathyroid glands 3. In normal thyroid function, what chemical messenger does the pituitary body produce?* A - T3 and T4 B - Thyroid releasing hormone C - Thyroid stimulating hormone D - Calcitonin 4. What is the most common cause of thyroid dysfunction?* A - Cancer B - Autoimmune disease C - Surgically induced D - Pregnancy E - Medication toxicity or side effect 5. Which of the following causes the thyroid eye disease in the congestive autoimmune form phase?* A - Thyroid antibodies B - Triiodothyronine (T3) C - Thyroxine (T4) D - Calcitonin 6. Which thyroid dysfunction accounts for 80% of the thyroid eye disease (TED) cases?* A - Hashimoto's thyroiditis B - Atrophic thyroiditis C - Euthyroid disease D - Hyperthyroid 7. Nervousness, heat intolerance, sweating, tremor, and tachycardia are signs and symptoms of?* A - Hashimoto's thyroiditis B - Atrophic thyroiditis C - Euthyroid disease D - Hyperthyroid 8. Which grading scale grades severity and activity? Also used in the clinical trials and studies for Teprotumumab-trbw (Tepezza).* A - NOSPECS grading system B - YESSPECS grading system C - LEMO classification D - Clinical Activity Score (CAS) 9. Thyroid eye disease is an inflammation of the?* A - Orbit B - Retinal C - Aqueous and vitreous D - Meibomian glands 10. Which ocular complication is most seen in thyroid eye disease, especially in Grave’s disease?* A - Lid retraction B - Restrictive myopathy C - Optic neuropathy D - Exophthalmos 11. Which term is reserved for the prominence of the eye caused by increased volume of the extra ocular muscles secondary to thyroid disease?* A - Exophthalmos B - Lid retraction C - Periorbital edema D - Optic neuropathy 12. Which phase is the best time to recommend surgery for thyroid eye disease?* A - Phase secondary to abnormal thyroid hormone levels B - Active “inflammatory” phase C - Plateau phase and Resolution “Passive” phase D - Thyroid eye disease never requires a surgical consult 13. Thyroid eye disease can lead to severe loss of vision in 5.0% of the patients. Which ocular complication of thyroid eye disease is the most likely cause of the severe vision loss?* A - Optic neuropathy B - Periorbital edema C - Restrictive myopathy D - Lid retraction 14. Which statement is true about thyroid eye disease?* A - It never leads to facial disfigurement B - If facial disfigurement occurs, it is rarely noticeable C - The facial disfigurement can cause depression D - The facial disfigurement never causes depression 15. Which biologic drug is indicated for thyroid eye disease?* A - Teprotumumab-trbw (Tepezza) B - Cenegermin–bkbj (Oxervate) C - Tocilizumab (Actemra) D - Adalimumab (Humira) 16. Which of the following mechanisms most closely describes how Teprotumumab-trbw (Tepezza) works?* A - It binds to IGF-1 receptor and blocks its activation and signaling. B - It is an exact copy human nerve growth factor. C - It blocks vascular endothelial growth factor. D - It binds to TNF and blocks its action in the body 17. An adverse drug reaction for Teprotumumab-trbw (Tepezza) is?* A - Hyperglycemia B - Hypoglycemia C - Low blood pressure D - Low intraocular pressure 18. Teprotumumab-trbw (Tepezza) is administrated as?* A - Eye drop B - Orbital injection C - Infusion D - Orally 19. The mechanism of action of Teprotumumab-trbw (Tepezza) is?* A - Antibiotic B - Antiviral C - Increased uveal scleral outflow D - Immunomodulary 20. Which nutrients help increase the conversion of T4 to T3?* A - Selenium and zinc B - Lutein and zeaxanthin C - Vitamins A, C, and E D - Vitamin D and K2 Personal InformationName* First Last Email* Phone*OE Tracker #License #Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationPromotional CodeQuebec 2024 - The ABCs of Thyroid Eye Disease - Antibodies, Biologics, and Clinical Pearls | TQ Credit*After 10/23/2024, pricing will increase to $30. Price: (Past 60 Days) Quebec 2024 - The ABCs of Thyroid Eye Disease - Antibodies, Biologics, and Clinical Pearls | TQ CreditThis course was presented over 60 days ago. Due to this late submission of TQ, your TQ credit price is $30. Price: Retake Discount Price: Promotional Discount Price: (Past 60 Days) Retake Discount Price: (Past 60 Days) Promotional Discount Price: Credit Card* This field is hidden when viewing the formCourse Information (HIDDEN)This field is hidden when viewing the formCourse Name (HIDDEN)This field is hidden when viewing the formRetake Code (HIDDEN)This field is hidden when viewing the formQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/)This field is hidden when viewing the formCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
